Literature DB >> 9131648

Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency.

E Tan1, H Topaloglu, C Sewry, Y Zorlu, I Naom, S Erdem, M D'Alessandro, F Muntoni, V Dubowitz.   

Abstract

Merosin-deficient congenital muscular dystrophy (CMD) is an autosomal recessive condition usually with onset at birth or within the first months of life. Affected children are severely disabled and usually do not achieve the ability to walk without support. They invariably have white matter abnormalities on brain magnetic resonance imaging (MRI). We report a 29-year-old man with a late childhood onset limb-girdle type muscular dystrophy and cerebral white matter changes on MRI. Immunocyto-chemical studies of the patient's muscle biopsy showed a reduction in expression of the laminin alpha 2 chain of merosin. The patient had three affected siblings, and microsatellite genotyping confirmed linkage to the laminin alpha 2 locus (LAMA2) on chromosome 6q2 in this family. This case probably represents a milder allelic variant of classical merosin-deficient CMD. Merosin status should be assessed in patients with late-onset limb girdle muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131648     DOI: 10.1016/s0960-8966(96)00421-x

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

1.  A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families.

Authors:  P Dinçer; Z Akçören; E Demir; I Richard; O Sancak; G Kale; S Ozme; A Karaduman; E Tan; J A Urtizberea; J S Beckmann; H Topaloğlu
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

2.  Merosin-deficient congenital muscular dystrophy with cerebral white matter changes: a clue to its diagnosis beyond infancy.

Authors:  Sandeep Kumar; Shrikiran Aroor; Suneel Mundkur; Maneesh Kumar
Journal:  BMJ Case Rep       Date:  2014-03-06

3.  Multiplex Western blotting system for the analysis of muscular dystrophy proteins.

Authors:  L V Anderson; K Davison
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 4.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

5.  Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.

Authors:  K J Jones; S S Kim; K N North
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

Review 6.  Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.

Authors:  Peter D Yurchenco; Karen K McKee; Judith R Reinhard; Markus A Rüegg
Journal:  Matrix Biol       Date:  2017-11-27       Impact factor: 11.583

7.  Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.

Authors:  Yung-Yao Lin; Richard J White; Silvia Torelli; Sebahattin Cirak; Francesco Muntoni; Derek L Stemple
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

8.  Novel Mutation (c.8725T>C) in Two Siblings With Late-Onset LAMA2-Related Muscular Dystrophy.

Authors:  Min Wook Kim; Dae Hyun Jang; Jun Kang; Seungok Lee; Sun Young Joo; Ja Hyun Jang; Eun Hae Cho; Young Chul Choi; Jung Hwan Lee
Journal:  Ann Lab Med       Date:  2017-07       Impact factor: 3.464

Review 9.  Neuromuscular disorders in zebrafish: state of the art and future perspectives.

Authors:  Andrea Pappalardo; Letizia Pitto; Chiara Fiorillo; M Alice Donati; Claudio Bruno; Filippo M Santorelli
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

10.  Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy.

Authors:  Radhika Mhatre; Deepha Sekar; Jessiena Ponmalar; Madhu Nagappa; Preethish-Kumar Veeramani; Kiran Polavarapu; Seena Vengalil; Nalini Atchayaram; Gayathri Narayanappa
Journal:  Ann Indian Acad Neurol       Date:  2020-07-24       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.